TFS HealthScience Case Studies

  1. Rapid Results In A High-Stakes Dry Eye Disease Trial 6/26/2025

    This time-sensitive Phase 3 trial in dry eye disease required precision project management leveraging strong site relationships, ophthalmology-specific expertise, and data-driven site selection.

  2. Global Start-Up For Multinational Geographic Atrophy Trial 6/26/2025

    This partnership allowed a leading biopharmaceutical company to navigate the complexities of a Phase IIb study investigating a novel pegylated RNA adapter for geographic atrophy secondary to dry AMD.

  3. Precision Project Management In Action 6/12/2025

    Discover how a tailored, risk-based project management approach was used to overcome the challenges of a complex Phase I/IIa FIH multi-country study of an advanced therapy medicinal product (ATMP).

  4. Driving Early-Phase Success In Advanced Solid Tumors Study 3/24/2025

    ​A European biotech company collaborated with TFS HealthScience to conduct an early-phase clinical trial focusing on advanced and metastatic solid tumors.

  5. Supporting A CAR T-Cell Therapy Study In Hematologic Malignancies 3/24/2025

    To address a life-threatening complication of immunotherapy in hematologic malignancies, a U.S. biotech company developed a novel compound.

  6. Streamlining Phase I/II Oncology Trials: A Global CRO Partnership 3/17/2025

    Through strategic planning, adaptive trial execution, and proactive collaboration, TFS successfully navigated the complexities of this early-phase oncology study.

  7. Tailored Solutions For A Global Phase III Neovascular AMD Study 3/17/2025

    How did a Phase III combination study for neovascular age-related macular degeneration (AMD) overcome study complexities while expanding across 16 countries?

  8. Optimizing Early-Stage Oncology 1/14/2025

    A strategic partnership enables a U.S. biotech company to address the struggles with their Phase I first-in-human oncology trial.

  9. Addressing Site Selection Challenges In DMD Gene Therapy Studies 1/14/2025

    Effective site selection is critical for the success of DMD gene therapy trials. This study details innovative methodologies employed to streamline and improve site identification.